z-logo
open-access-imgOpen Access
The variances of hematology of gurami (Osphronemus gouramy) which is vaccinated and challenged by Aeromonas hydrophila
Author(s) -
D. Alfaniah,
Rahayu Kusdarwati,
Rozi,
Didik Handijatno
Publication year - 2020
Publication title -
iop conference series. earth and environmental science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.179
H-Index - 26
eISSN - 1755-1307
pISSN - 1755-1315
DOI - 10.1088/1755-1315/441/1/012042
Subject(s) - aeromonas hydrophila , biology , aeromonas , immune system , vaccination , microbiology and biotechnology , vibrionaceae , bacteria , fish <actinopterygii> , immunology , fishery , genetics
Freshwater fish that became the leading commodity of gourami. Fish cultivation is often experienced constraints of infection from motile aeromonas septicaemia (MAS), also known as red spotting disease caused by bacteria Aeromonas hydrophila . A vaccine is an effective preventive measure because in this way immune can be obtained only once or twice vaccine administration until the fish is harvested. This study aims to determine the haematological picture of gourame ( Osphronemus gouramy ) that vaccinated and challenged bacteria Aeromonas hydrophila . This research is an experimental research using completely randomized design which consists of 5 treatments and 4 replications. The treatment of this study was the difference of vaccine dose ie A (control +) fish injected vaccine without any challenge test, B (control -) fish injected NaCl Physiological and tested challenge, C vaccine dose 10 4 CFU/mL, D vaccine dose 10 5 CFU/mL, and E vaccine dose of 10 6 CFU/mL. The results of this study showed vaccinations and tests of bacteria Aeromonas hydrophila in gouramy can give effect to total erythrocytes, hemoglobin, leukocyte total, and leukocyte differential. The 10 6 cell/mm 3 (E) vaccine dose provides the best (responsive immune response) effectiveness compared to the other two doses.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here